Myomo Files for Reg A+ Offer. Expects to List on NYSE Following Funding Round
Myomo, a medical robotics company whose products enable users to overcome upper extremity paralysis, has filed a Form 1-A with the SEC indicating its intent to raise money under Reg A+, a crowdfunding exemption that allows issuers to seek up to $50 million in capital…. Read More
Read more in: Offerings | Tagged banq, mark elonowitz, myo, myomo, nyse, regulation a, tripoint global